Abstract
The objective of this study was to evaluate the effects of various berry extracts, with and without clarithromycin on Helicobacter pylori. Resistance to clarithromycin by H. pylori has been reported, leading to interest in alternatives/adjuncts to therapy with clarithromycin. H. pylori American type culture collection (ATCC) strain 49503 was grown, cell suspensions were made in PBS and diluted 10-fold. One hundred μl of the suspension was then incubated for 18 h with extracts of raspberry, strawberry, cranberry, elderberry, blueberry, bilberry, and OptiBerry®, a blend of the six berries, at 0.25–1% concentrations. Serially diluted cell suspensions were exposed for 1 h to clarithromycin at 15 μg/ml. Ten μl of bacterial samples from the 10−7 dilution tube were plated and incubated for 18 h and the number of colonies were counted. Growth of H. pylori was confirmed by the CLO® test. All berry extracts significantly (p < 0.05) inhibited H. pylori, compared with controls, and also increased susceptibility of H. pylori to clarithromycin, with OptiBerry® demonstrating maximal effects. (Mol Cell Biochem 265: 19–26, 2004)
Similar content being viewed by others
References
Wang J, Brooks EG, Bamford KB, Denning TL, Pappo J, Ernst PB: Negative selection of T cells by Helicobacter pylori as a model for bacterial strain selection by immune evasion. J Immun 167: 926–934, 2001
Yang Y, Yang J, Jeng Y, Chang M, Ni Y: Prevalence and rapid identifica-tion of clarithromycin resistant Helicobacter pylori isolates in children.Pediatr Infect Dis J 20: 662–666, 2001
Moss SF: The carcinogenic effect of H. pylori on the gastric epithelial cell. J Physiol Pharmacol 50: 847–856, 1999
Chatterjee A, Yasmin T, Bagchi D, Stohs SJ: The bactericidal effects of Lactobacillus acidophilus,garcinol and Protykin®compared to clar-ithromycin, on Helicobacter pylori.Mol Cell Biochem 243: 29–35, 2003
Sharon N, Ofek I: Fighting infectious diseases with inhibitors of mi-crobial adhesion to host tissues. Crit Rev Food Sci Nutr 42: 267–272, 2002
Burger O, Weiss E, Sharon N, Tabak M, Neeman I, Ofek I: Inhibition of Helicobacter pylori adhesion to human gastric mucus by a high-molecular-weight constituent of cranberry juice. Crit Rev Food Sci Nutr 42: 279–284, 2002
Burger O, Ofek I, Tabak M, Weiss EI, Sharon N, Neeman I: A high molecular mass constituent of cranberry juice inhibits Helicobacter pylori adhesion to human gastric mucus. FEMS Immunol Med Mi-crobiol 29: 295–301, 2000
Bagchi D, Bhattacharya G, Stohs SJ: Production of reactive oxygen species by gastric cells in association with Helicobacter pylori. Free Radic Res 24: 439–450, 1996
Bagchi D, McGinn TR, Ye X, Bagchi M, Krohn RL, Chatterjee A, Stohs SJ: Helicobacter pylori-induced oxidative stress and DNA damage in a primary culture of human gastric mucosal cells. Dig Dis Sci 47: 1405–1412, 2002
Bagchi M, Sen CK, Kothari SC, Preuss HG, Stohs SJ, Bagchi D: An-tioxidant and anticarcinogenic properties of edible berry anthocyanins. The Original Internist March 06-14, 2003
Howell AB, Vorsa N, Der Marderosian A, Foo LY: Inhibition of the adherence of P-fimbriated Esherichia coli to uroepithelial-cell surfaces by proanthocyanidin extracts from cranberries. NEngl J Med 339: 1085–1086, 1998
Camire ME: Bilberries and blueberries as functional foods and nutraceuticals. In: Herbs, Botanicals & Teas. Technomic Publishing Company, Lancaster, PA, 2000, pp 289–319
Cao G, Russell RM, Lischner N, Prior RL: Serum antioxidant capacity is increased by consumption of strawberries, spinach, red wine or vitamin C inelderly women. J Nutr 128: 2383–2390, 1998
Youdim KA, Martin A, Joseph JA: Incorporation of the elderberry anthocyanins by endothelial cells increases protection against oxidative stress. Free Radic Biol Med 29: 51–60, 2000
Liu M, Li XQ, Weber C, Lee CY, Brown J, Liu RH: Antioxidant and antiproliferative activities of raspberries. J Agric Food Chem 50: 2926–2930, 2002
Pedersen CB, Kyle J, Jenkinson AM, Gardner PT, McPhail DB, Duthie GG: Effects of blueberry and cranberry juice consumption on the plasma antioxidant capacity of healthy female volunteers. Eur J Clin Nutr 54: 405–408, 2000
Cover TL, Blaser MJ: Purification and characterization of the vacuolating toxin from Helicobacter pylori.JBiol Chem 267: 10570–10575, 1992
Bagchi D, Bagchi M, Stohs SJ, Das DK, Ray SD, Kuszynski CA, Joshi SS, P ruess HG: Free radicals and grape seed proanthocyanidin extract: Importance in human health and disease prevention. Toxicology 148: 187–197, 2000
Roy S, Khanna S, Alessio HM, Vider J, Bagchi D, Bagchi M, Sen CK: Anti-angiogenic property of edible berries. Free Radic Res 36: 1023–1031, 2002
Marshall BJ, Warren JR, Francis GJ, Langton SR, Goodwin CS, Blincow ED: Rapid urease test in the management of Campylobacter pyloridis-associated gastritis. Am J Gastroenterol 82: 200–210, 1987
Wilkinson: Helicobacter pylori:Anoverview. Br J Biomed Sci 58: 59–60, 2001
Brown LM: Helicobacter pylori: Epidemiology and routes of transmis-sion. Epidemiol Rev 22: 283–297, 2000
Blaser MJ, Berg DE: Helicobacter pylori genetic diversity and risk of human disease. J Clin Invest 107: 767–773, 2001
Fennerty MB: Helicobacter pylori. Arch Intern Med 154: 721–727, 1994
Leung WK, Graham DY: Clarithromycin for Helicobacter pylori infec-tion. Expert Opin Pharmacother 1: 507–514, 2000
Davies GR, Simmonds NJ, Stevens TR, Sheaff MT, Banatvala N, Laurenson IF, Blake DR, Rampton DS: Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 35: 179–185, 1994
Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1(8390): 1311–1315, 1984
Levi S, Beardshall K, Haddad G, Playford R, Ghosh P, Calam J: Campy-lobacter pylori and duodenal ulcers, the gastrin link. Lancet 1(8648): 1167–1168, 1989
Aguilar GR, Ayala G, F ierros-Zarate G: Helicobacter pylori: Recent advances in the study of its pathogenicity and prevention. Salud Publica Mex 43: 237–247, 2001
Kozu T, Saito D: Helicobacter pylori & gastric disease. Rinsho Byori 49: 121–125, 2001
van der Vliet A, Bast A: Role of reactive oxygen species in intestinal diseases. Free Rad Biol Med 12: 499–513, 1992
McCord JM: Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312: 159–163, 1985
Adkison D, Hollwarth ME, Benoit JN, Parks DA, McCord JM, Granger DN: Role of free radicals in ischemia-reperfusion injury to the liver. Acta Physiol Scand Suppl 548: 101–107, 1986
Schoenberg MH, Buchler M, Gaspar M, Stinner A, Younes M, Melzner I, Bultmann B, Beger HG: Oxygen free radicals in acute pancreatitis of the rat. Gut 31: 1138–1143, 1990
Simmonds NJ, Rampton DS: Inflammatory bowel disease-A radical review. Gut 34: 865–868, 1993
Mansbach CM 2nd, Rosen GM, Rahn CA, Strauss KE: Detection of free radicals as a consequence of rat intestinal cellular drug metabolism. Biochim Biophys Acta 888: 1–9, 1986
Salim AS: The relationship between Helicobacter pylori and oxygen-derived free radicals in the mechanism of duodenal ulceration. Intern Med 32: 359–364, 1993
Ching TL, Haenen GR, Bast A: Cimetidine and other H2-receptor an-tagonists as powerful hydroxyl radical scavengers. Chem Biol Interact 86: 119–127, 1993
Helicobacter pylori Infections. In: Red Book 2003. Report of the Com-mittee on Infectious Diseases. American Academy of Pediatrics, 26th edn. Elk Grove Village, IL, 2003, pp 304–305.
Hsieh PF, Yang JC, Lin JT, Wang JT: Molecular mechanisms of clarithromycin resistance in Helicobacter pylori.J Formos Med Assoc 97: 445–452, 1998
Hulten K, Gibreel A, Skold O, Engstrand L: Macrolide resis-tance in Helicobacter pylori:Mechanism and stability in strains from clarithromycin-treated patients. Antimicrob Agents Chemother 41: 2550–2553, 1997
Yamaguchi F, Saito M, Ariga T, Yoshimura Y, Nakazawa H: Free radical scavenging activity and antiulcer activity of garcinol from Garcinia indica fruit rind. J Agric Food Chem 48: 2320–2325, 2000
Mahady GB, Pendland S: Resveratrol inhibits growth of Helicobacter pylori in vitro. Am J Gastroenterol 95: 1849, 2000
Daroch F, Hoeneisen M, Gonzalez CL, Kawaguchi F, Salgado F, Solar H, Garcia A: In vitro antibacterial activity of Chilean red wines against Helicobacter pylori. Microbios 104: 79–85, 2001
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chatterjee, A., Yasmin, T., Bagchi, D. et al. Inhibition of Helicobacter pylori in vitro by various berry extracts, with enhanced susceptibility to clarithromycin. Mol Cell Biochem 265, 19–26 (2004). https://doi.org/10.1023/B:MCBI.0000044310.92444.ec
Issue Date:
DOI: https://doi.org/10.1023/B:MCBI.0000044310.92444.ec